Asset
Colchicine
Scilex Holding Company Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (4)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01601132 | phase4 | completed | 2012-05-01 | 2012-07-01 | Takeda | Drug Interaction Study of Colchicine and Theophylline |
| NCT02139046 | phase3 | completed | 2014-04-01 | 2015-11-01 | Takeda | Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout |
| NCT02128490 | phase2 | completed | 2014-05-01 | 2015-09-01 | Takeda | Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment |
| NCT01084278 | phase4 | completed | 2010-05-01 | 2011-02-01 | Takeda | Healthy and Renal Impairment Study of Colcrys (Colchicine, USP) |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 210942 | NDA | SCILEX PHARMACEUTICALS INC |
Marketed products (1)
- GLOPERBA